date,company_id,signal_type,value,note,detailed_description,source,impact_on_c008
2020-04-07,C008,Product Launch,1,NeuraDiagnose launch,Early NHS pilot traction,Internal,Pilot ARR +$1.2M
2020-09-18,C008,Patent Filing,3,Explainability patents,Increased IP defenses,USPTO,Moat +
2021-09-02,C008,Product Beta Release,1,PredictCare Oncology,Pipeline boost $3.5M,Internal,Pipeline +
2022-06-16,C008,Regulatory Milestone,1,FDA Breakthrough Designation,Accelerated US access,FDA,Market boost
2023-01-10,C008,Funding Round,60,$60M Series C,Received from UK and US banks,PitchBook,Runway extended
2023-11-14,C008,Customer Win,8,NHS 5-hospital rollout,Enterprise health system win,Contracts,ARR +$8M
2024-03-27,C008,Reputation Hit,-1,Data bias claims,Media scrutiny and audit,Social,Lead velocity -10%
2024-08-19,C008,Audit Clearance,1,Audit passed,Third-party confirmation,Report,Sentiment recovery
2025-02-10,C008,Strategic JV,1,JV with C003 and Medisafe,Cross-sector collaboration,Press Release,Pipeline synergy +
2025-05-23,C008,Pricing Strategy,1,Value-based pricing,Improved renewals,Internal,Retention +
2025-07-15,C008,Regulatory Guidance,1,MHRA AI Device Guidance,Compliance enabled,Regulator,Approval risk reduced
2025-08-19,C008,Earnings Beat,1,Q2 2025 earnings,EPS and ARR growth,Company,Stock rise
2020-11-25,C008,Partnership,1,Mayo Clinic collaboration,Clinical validation partnership,Press,Credibility boost
2021-02-18,C008,Patent Grant,1,Diagnostic algorithm,Core IP protection,USPTO,Competitive edge
2021-06-30,C008,Contract Win,2.5,Genentech pharma,Drug development analytics,Contracts,Revenue expansion
2021-12-15,C008,Certification,1,ISO 13485,Medical device quality system,ISO,Market access
2022-03-08,C008,Product Launch,1,NeuroGenomics platform,Genomic analysis capability,Internal,Market expansion
2022-09-22,C008,Industry Recognition,1,HIMSS keynote,Thought leadership platform,Conference,Brand recognition
2023-03-14,C008,Strategic Partnership,4.2,Medisafe Health integration,Healthcare platform expansion,Partnership,Revenue growth
2023-06-28,C008,Regulatory Progress,1,FDA pre-cert pathway,Software medical device route,FDA,US acceleration
2023-08-10,C008,Team Scaling,85,AI research expansion,Research capability increase,HR,Innovation capacity
2024-01-15,C008,Security Partnership,1,Cobalt integration,Healthcare AI security,Partnership,Differentiation
2024-05-30,C008,Product Enhancement,1,Explainable AI tools,Clinical transparency,Internal,User adoption
2024-09-12,C008,Clinical Validation,25,NHS outcomes study,Diagnostic accuracy improvement,Clinical,Evidence building
2024-12-03,C008,Industry Award,1,Healthcare AI innovation,Industry recognition,Awards,Brand strength
2025-01-22,C008,Advanced Patent,1,Federated learning,Privacy-preserving training,USPTO,Technology leadership
2025-04-09,C008,Regulatory Approval,1,MHRA device approval,UK market clearance,MHRA,Market access
2025-06-18,C008,European Expansion,6.5,Multi-country deployment,European hospital network,Contracts,Geographic growth
2025-07-25,C008,Scientific Publication,1,Validation study,Peer-reviewed clinical evidence,Academic,Credibility
2025-08-01,C008,Market Position,1,Diagnostic AI leader,Industry leadership recognition,Analyst,Positioning
